Hydrocodone/pseudoephedrine - Pernix TherapeuticsAlternative Names: Pseudoephedrine/hydrocodone - Pernix Therapeutics; REZIRA
Latest Information Update: 17 Jul 2015
At a glance
- Originator Cypress Pharmaceutical
- Class Antitussives; Decongestants; Morphinans; Opioid analgesics; Opioid peptides; Propanolamines; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Opioid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Common cold; Cough